Clinical Trials Directory

Trials / Conditions / Relapsed Follicular Lymphoma

Relapsed Follicular Lymphoma

9 registered clinical trials studyying Relapsed Follicular Lymphoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingRelapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy
NCT05848765
University of BirminghamPhase 2
Active Not RecruitingA Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies
NCT05828589
BeOne MedicinesPhase 1
WithdrawnZandelisib + Tazemetostat in R/R Follicular Lymphoma
NCT05604417
Jacob Soumerai, MDPhase 1 / Phase 2
TerminatedStudy to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Rel
NCT04699461
ADC Therapeutics S.A.Phase 2
CompletedReduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
NCT04191187
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
CompletedStudy of Safety and Efficacy of Betalutin and Rituximab in Patients With FL
NCT03806179
Nordic NanovectorPhase 1
CompletedIbrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
NCT02956382
Georgetown UniversityPhase 1 / Phase 2
UnknownA Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)
NCT01827605
Fondazione Italiana Linfomi - ETSPhase 3
CompletedPhase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma
NCT00715208
Millennium Pharmaceuticals, Inc.Phase 2